Development and survival of MYC-driven lymphomas require the MYC antagonist MNT to curb MYC-induced apoptosis.

Added 576 days ago (21.10.2020)
Authors: Nguyen HV, Vandenberg CJ, Ng AP, Robati MR, Anstee NS, Rimes J, Hawkins ED, Cory S
PubMed id: 31978211
Read article